From Population to Sample — How Many and Who?
ICMR COVID-19 Serosurvey (2020):
Two fundamental questions:
How can 29,000 people represent 1.4 billion?
Every individual has an equal probability of selection.
When to use:
Limitation:
Select every k-th individual from the frame.
Example (NFHS):
Advantage: Simpler than SRS, spreads evenly
Risk: Periodicity bias (if list has hidden pattern)
Divide population into strata, sample from each.
Why stratify?
Example (NFHS-5):
Randomly select whole clusters, sample everyone within.
Why use clusters?
Disadvantage:
The real-world approach — used by NFHS and ICMR.
Each stage introduces sampling error — multi-stage designs require larger samples than SRS to achieve the same precision.
| Method | How It Works | Best For | Precision |
|---|---|---|---|
| Simple Random | Random selection from complete list | Small well-defined populations | High |
| Systematic | Every k-th person from list | Large lists without subgroups | High |
| Stratified | Divide into strata, sample each | Ensuring subgroup representation | Highest |
| Cluster | Select whole clusters, sample all within | Large geographic spread, no frame | Lower |
| Multi-Stage | Hierarchical selection at multiple levels | National surveys (NFHS, ICMR) | Lower |
| Method | How | When Acceptable | Risk |
|---|---|---|---|
| Convenience | Whoever is available | Pilot studies, feasibility | Selection bias |
| Purposive | Researcher selects specific cases | Qualitative, rare diseases | Not generalizable |
| Snowball | Participants recruit others | Hidden populations (MSM, PWID) | Network bias |
| Quota | Fill predefined categories | Market research, quick surveys | Subjective selection |
Key rule: Non-probability sampling cannot support statistical inference (no valid CIs or p-values). Use only when probability sampling is impossible.
SE quantifies typical sampling error.
\[SE_{\bar{x}} = \frac{\sigma}{\sqrt{n}}\]
\[SE_{\hat{p}} = \sqrt{\frac{p(1-p)}{n}}\]
Key insight (CLT):
Margin of Error (MOE) = how far our estimate might be from the truth.
\[MOE = z_{\alpha/2} \times SE\]
For 95% confidence: MOE = 1.96 × SE
Example: HbA1c in 64 diabetic patients, mean = 11.5, SD = 1.6
“We are 95% confident the true mean HbA1c is between 11.11 and 11.89 g/dL.”
\[n = \frac{z^2_{\alpha/2} \times p(1-p)}{E^2}\]
Where:
If p is unknown: Use p = 0.5 (maximizes sample size — conservative)
Worked Example:
Estimate diabetes prevalence in Bhopal.
\[n = \frac{1.96^2 \times 0.10 \times 0.90}{0.02^2}\]
\[n = \frac{3.8416 \times 0.09}{0.0004} = \frac{0.346}{0.0004}\]
\[\boxed{n = 864}\]
| Reject H₀ | Fail to Reject H₀ | |
|---|---|---|
| **H₀ TRUE** (No effect) | ❌ **Type I Error (α)** False Positive P = 0.05 | ✅ **Correct** True Negative P = 1 − α = 0.95 |
| **H₀ FALSE** (Effect exists) | ✅ **Correct** (Power) True Positive P = 1 − β = 0.80 | ❌ **Type II Error (β)** False Negative P = 0.20 |
Key trade-off: Decreasing α increases β. Solution: increase sample size!
Convention: α = 0.05, β = 0.20 (Power = 80%)
\[n_{per\ group} = \frac{2(z_{\alpha/2} + z_{\beta})^2 \times \sigma^2}{\delta^2}\]
Where:
Worked Example:
New antihypertensive vs standard.
\[n = \frac{2(1.96 + 0.84)^2 \times 15^2}{10^2}\]
\[= \frac{2 \times 7.84 \times 225}{100}\]
\[\boxed{n = 36 \text{ per group}}\]
\[n = \frac{2(z_{\alpha/2} + z_{\beta})^2 \times [p_1(1-p_1) + p_2(1-p_2)]}{(p_2 - p_1)^2}\]
Where:
Worked Example:
TB cure rate: 70% → 85%.
\[n = \frac{2 \times 7.84 \times [0.70 \times 0.30 + 0.85 \times 0.15]}{(0.85 - 0.70)^2}\]
\[= \frac{2 \times 7.84 \times [0.21 + 0.1275]}{0.0225}\]
\[= \frac{2 \times 7.84 \times 0.3375}{0.0225}\]
\[\boxed{n \approx 94 \text{ per group}}\]
Not all enrolled subjects complete the study. Adjust upward:
\[n_{adjusted} = \frac{n}{1 - \text{dropout rate}}\]
Example: TB drug trial needs 94 per group. Expected dropout = 15%.
\[n_{adjusted} = \frac{94}{1 - 0.15} = \frac{94}{0.85} \approx 111 \text{ per group}\]
Always report both: “We calculated n = 94 per group, inflated to 111 to account for 15% expected dropout.”
Cluster sampling inflates variance because individuals within clusters are similar.
\[DE = 1 + (m - 1) \times \rho\]
Where:
\[n_{adjusted} = n_{SRS} \times DE\]
Example:
\[DE = 1 + (12 - 1) \times 0.02 = 1.22\]
\[n_{adjusted} = 36 \times 1.22 \approx 44 \text{ per group}\]
Key insight: Even small ICC (ρ = 0.02) with large clusters can substantially inflate required n.
Then adjust for: dropouts → design effect → finite population correction
| Purpose | Formula | Key Inputs |
|---|---|---|
| Estimate proportion | \(n = z^2 p(1-p) / E^2\) | p, margin of error |
| Estimate mean | \(n = z^2 \sigma^2 / E^2\) | σ, margin of error |
| Compare two means | \(n = 2(z_\alpha + z_\beta)^2 \sigma^2 / \delta^2\) | σ, effect size, power |
| Compare two proportions | See formula above | p₁, p₂, power |
| Dropout adjustment | \(n_{adj} = n / (1 - d)\) | dropout rate |
| Design effect | \(DE = 1 + (m-1)\rho\) | cluster size, ICC |
Remember: z₀.₀₂₅ = 1.96 (95% CI) • z₀.₂₀ = 0.84 (80% power) • z₀.₁₀ = 1.28 (90% power)
Biostatistics for Clinicians | Module 6